Tirzepatide 45MG
$140.00
Tirzepatide 45MG is a 45-milligram format of tirzepatide, a synthetic peptide analogue engineered from incretin hormone motifs. Researchers study tirzepatide for its potential activity at incretin receptor pathways and for how such signaling may relate to metabolic regulation in preclinical and clinical research contexts.
In Stock
Tirzepatide 45MG is a 45-milligram format of tirzepatide, a synthetic dual incretin receptor peptide designed to mimic aspects of endogenous incretin hormones. It is investigated in research settings where peptide agonism at incretin receptors is examined alongside downstream signaling, pharmacology, and biomarker readouts.
Studies have examined tirzepatide in the context of glucose homeostasis, energy balance, and cardiometabolic endpoints, typically using controlled experimental models and clinical study designs. Tirzepatide 45MG may be used as a reference material in method development and receptor pathway research where defined peptide identity is required.
- Specification: 45MG
This product is intended for laboratory and research purposes only. Not for human consumption.
| Weight | 0.2 kg |
|---|---|
| Dimensions | 5 × 5 × 5 cm |
Related Products
Cagrilintide 5MG is a 5-milligram format of cagrilintide, a long acting amylin analogue peptide engineered for extended receptor activity. Researchers study amylin analogues in the context of metabolic signaling, appetite regulation pathways, and gastric emptying models.
In Stock
Trenbolone Enanthate 125Mg; Drostanolone Enanthate 125Mg; Testosterone Enanthate 125Mg – 500mg/ml, 10ml is a multi compound anabolic androgenic steroid preparation featuring three long ester derivatives of trenbolone, drostanolone, and testosterone. Researchers may reference this combination when examining androgen receptor driven signaling, ester linked pharmacokinetics, and analytical detection methods in complex steroid mixtures. Studies have also considered how mixed esterified steroids behave in chromatography and mass spectrometry workflows.
In Stock
Semaglutide 30MG is a 30-milligram format of semaglutide, a synthetic GLP-1 receptor agonist peptide analogue. Researchers study semaglutide in the context of incretin signaling, glucose regulation pathways, and appetite related neuroendocrine models. It is a modified peptide designed to extend stability relative to native GLP-1.
In Stock
Tirzepatide 20MG is a 20-milligram format of tirzepatide, a synthetic peptide studied as a dual GIP and GLP 1 receptor agonist. Researchers examine tirzepatide in metabolic research, including models related to glycemic regulation, appetite signaling, and energy balance.
In Stock
Winstrol 100mg/ml 10ml refers to a 100 milligram per millilitre concentration supplied in a 10 millilitre format of stanozolol, a synthetic anabolic androgenic steroid derived from dihydrotestosterone. Researchers may reference stanozolol in studies involving androgen receptor signaling, anabolic steroid structure activity relationships, and metabolism profiling.
In Stock
Superdrol / Methyldrostanolone 50mg/ml, 10ml refers to a defined concentration and volume format of methyldrostanolone, a 17 alpha alkylated synthetic anabolic androgenic steroid related to dihydrotestosterone analogues. Researchers have examined methyldrostanolone in studies of androgen receptor activity and anabolic androgenic structure activity relationships.
In Stock
Semaglutide 5MG is a 5-milligram format of semaglutide, a synthetic GLP 1 receptor agonist peptide analogue. It is studied as an acylated peptide engineered for extended stability in biological systems. Researchers have examined semaglutide in preclinical and translational work involving incretin signaling and metabolic regulation pathways.
In Stock
Tirzepatide 15MG is a 15-milligram format of tirzepatide, a synthetic peptide studied as a dual agonist at the GIP and GLP 1 receptors. It is of interest in metabolic and endocrine research where incretin signaling is examined. Studies have evaluated tirzepatide in preclinical and clinical settings to better understand receptor bias, signaling kinetics, and downstream biomarker changes.
In Stock
Cagrilintide 10MG is a 10-milligram format of cagrilintide, a long acting amylin analogue peptide designed to engage amylin receptor pathways. Researchers study cagrilintide in preclinical and translational settings involving appetite signalling, gastric emptying models, and metabolic regulation.
In Stock
Trenbolone Enanthate 250Mg; Drostanolone Enanthate 250Mg – 500mg/ml, 10ml is a combined format of two anabolic androgenic steroid esters: trenbolone (a 19 nor testosterone derivative) and drostanolone (a DHT derived analogue). Researchers may reference these compounds in studies involving androgen receptor signaling, esterified steroid pharmacokinetics, and analytical method development. Work in the literature commonly discusses trenbolone and drostanolone in the context of endocrine pathways and structure activity relationships.
In Stock
Trenbolone Acetate 75Mg, Trenbolone Enanthate 125Mg – 200mg/ml, 10 ml is a combined format of trenbolone in two ester forms: acetate and enanthate. Trenbolone is a synthetic anabolic androgenic steroid derived from 19-nortestosterone and widely referenced in endocrine and receptor binding research. Studies have examined esterified trenbolone in the context of androgen receptor signaling, pharmacokinetics, and steroid structure activity relationships.
In Stock
Trenbolone Hexahydrobenzyl Carbonate – 100mg/ml, 10ml is a specified format of trenbolone hexahydrobenzyl carbonate, a long ester derivative of trenbolone, a synthetic anabolic androgenic steroid (19 nor testosterone analogue). It is studied analytically in steroid ester profiling, reference standard comparison, and method development using chromatographic and mass spectrometric techniques.
In Stock
